Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
2.100
+0.030 (1.45%)
At close: Aug 1, 2025, 4:00 PM
2.030
-0.070 (-3.33%)
After-hours: Aug 1, 2025, 7:37 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $262.41 million as of August 1, 2025. Its market cap has increased by 280.63% in one year.
Market Cap
262.41M
Enterprise Value
233.16M
1-Year Change
280.63%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $262.41M, a decrease of -79.80%. That is a compound annual growth rate of -30.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 258.67M | 87.11% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | 1.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.56B |
| Johnson & Johnson | 405.20B |
| AbbVie | 336.43B |
| UnitedHealth Group | 239.68B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 225.13B |
| Novo Nordisk | 221.96B |